Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Access and reimbursement for HCV products Intellectual property reform. 
S. 1137 - PATENT Act & HR 9 - Innovation Act Funding for HCV and public health activities via appropriations. 

Pharmaceutical policy as it relates to payments under the 340B program.  

S.1287 - Viral Hepatitis Testing Act of 2015 Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products.
VET - Veterans CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS